Diagnostic Radiopharmaceuticals and Contrast Media

Diagnostic Radiopharmaceuticals and Contrast Media

Global Diagnostic Radiopharmaceuticals and Contrast Media Market to Reach US$13.6 Billion by 2030

The global market for Diagnostic Radiopharmaceuticals and Contrast Media estimated at US$10.6 Billion in the year 2023, is expected to reach US$13.6 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Contrast Media, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the Radiopharmaceuticals segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.7% CAGR

The Diagnostic Radiopharmaceuticals and Contrast Media market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Diagnostic Radiopharmaceuticals and Contrast Media Market - Key Trends and Drivers Summarized

How Are Diagnostic Radiopharmaceuticals and Contrast Media Revolutionizing Medical Imaging?

Diagnostic radiopharmaceuticals and contrast media are cornerstone technologies in modern medical imaging, enhancing the clarity and detail of images obtained via modalities such as MRI, CT scans, and PET scans. Radiopharmaceuticals involve the use of radioactive compounds that are administered to the patient to target specific tissues or organs. The emitted radiation from these compounds is then captured by specialized cameras to create detailed images of the body`s internal structures and functions, offering invaluable insights into a variety of diseases, including cancer, heart disease, and neurological disorders. Contrast media, on the other hand, are substances used to improve the visibility of internal bodily structures in imaging studies. These agents, which can be iodine-based or gadolinium-based depending on the imaging technique, help to clearly delineate between different types of tissues, making it easier for physicians to diagnose abnormalities or monitor disease progression.

What Technological Advancements Are Enhancing Diagnostic Imaging?

The field of diagnostic radiopharmaceuticals and contrast media is continually evolving, driven by technological advancements that aim to increase the efficacy and safety of these agents. Innovations in radiopharmaceuticals include the development of new radioactive tracers that have improved specificity for certain types of cancer cells, allowing for earlier detection and more precise targeting in treatment planning. Similarly, advances in contrast media are focused on enhancing the safety profiles of these agents, reducing the risk of adverse reactions, and improving the overall patient experience. Additionally, new formulation and delivery techniques are being developed to enhance the biocompatibility and effectiveness of contrast agents. These include nanoparticles and other encapsulation technologies that can improve the distribution and retention of these agents in the body, providing clearer and more detailed images.

How Do Diagnostic Radiopharmaceuticals and Contrast Media Impact Patient Care?

The use of diagnostic radiopharmaceuticals and contrast media has a profound impact on patient care, significantly improving the accuracy of diagnoses and the effectiveness of subsequent treatments. By enabling early detection of diseases and providing detailed insights into physiological and pathological processes, these agents allow for timely intervention, which can be critical in treating serious conditions such as cancer and heart disease. Moreover, the detailed information obtained from enhanced imaging guides physicians in planning more effective treatment strategies, monitoring responses to treatments, and adjusting therapies as needed. This precision in medical imaging not only improves outcomes but also minimizes unnecessary procedures, thereby reducing the overall healthcare costs and enhancing patient safety.

What Drives the Growing Market for Diagnostic Radiopharmaceuticals and Contrast Media?

The growth in the diagnostic radiopharmaceuticals and contrast media market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in medical imaging technologies, and a rising emphasis on personalized medicine. As populations age globally, the incidence of conditions such as cancer, cardiovascular diseases, and neurological disorders continues to rise, necessitating advanced diagnostic solutions for effective management. The continuous improvement in imaging technologies and the integration of artificial intelligence to analyze imaging data more efficiently are also significant contributors to market expansion. Furthermore, there is a growing demand for precise diagnostic tools that can tailor treatments to individual patient needs, aligning with the broader shift towards personalized healthcare. These drivers, coupled with increasing healthcare expenditure and improved healthcare infrastructure across emerging markets, ensure a dynamic and growing demand for diagnostic radiopharmaceuticals and contrast media, underscoring their essential role in modern medical practice.

Select Competitors (Total 38 Featured) -
  • AMAG Pharmaceuticals, Inc.
  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Daiichi Sankyo Co., Ltd.
  • GE Healthcare
  • Guerbet Group
  • Lantheus Holdings, Inc.
  • Mallinckrodt PLC
  • Medtronic PLC
  • Nordion, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Diagnostic Radiopharmaceuticals and Contrast Media – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growth in Cancer Prevalence Worldwide Spurs Demand for Enhanced Imaging Solutions
Technological Innovations in Radiopharmaceuticals Expand Therapeutic Applications
Increasing Use of PET and SPECT Scans Bolsters Market Growth
Development of Targeted Radiotracers Sets the Stage for Precision Medicine
Enhanced Focus on Patient Safety and Contrast Media Efficiency
Environmental and Health Concerns Regarding Gadolinium-based Agents
Growing Applications in Neurological and Cardiac Imaging Expand Market Reach
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 11: USA Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 12: USA Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: USA 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 15: Canada Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: Canada 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
JAPAN
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 17: Japan Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: Japan Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: Japan 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
CHINA
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 20: China Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: China Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: China 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
EUROPE
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 23: Europe Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: Europe Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: Europe 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 26: Europe Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Europe 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
FRANCE
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 29: France Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: France Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: France 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
GERMANY
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 32: Germany Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Germany Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Germany 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
ITALY
TABLE 35: Italy Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Italy Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Italy 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
UNITED KINGDOM
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 38: UK Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: UK Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: UK 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
SPAIN
TABLE 41: Spain Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Spain Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Spain 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
RUSSIA
TABLE 44: Russia Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Russia Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Russia 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Rest of Europe Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Rest of Europe 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Asia-Pacific 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Asia-Pacific 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
AUSTRALIA
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 56: Australia Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Australia Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Australia 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
INDIA
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 59: India Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: India Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: India 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 62: South Korea Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: South Korea Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: South Korea 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Rest of Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
LATIN AMERICA
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 68: Latin America Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 69: Latin America Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Latin America 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 71: Latin America Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Latin America Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Latin America 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 74: Argentina Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Argentina Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Argentina 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
BRAZIL
TABLE 77: Brazil Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Brazil Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Brazil 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
MEXICO
TABLE 80: Mexico Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Mexico Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Mexico 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Latin America Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Rest of Latin America 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
MIDDLE EAST
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 86: Middle East Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 87: Middle East Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Middle East 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 89: Middle East Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Middle East Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Middle East 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
IRAN
TABLE 92: Iran Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Iran Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Iran 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
ISRAEL
TABLE 95: Israel Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Israel Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Israel 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Saudi Arabia Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Saudi Arabia 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 101: UAE Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: UAE Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: UAE 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of Middle East Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of Middle East 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
AFRICA
Diagnostic Radiopharmaceuticals and Contrast Media Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 107: Africa Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Africa Historic Review for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Contrast Media and Radiopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Africa 16-Year Perspective for Diagnostic Radiopharmaceuticals and Contrast Media by Segment - Percentage Breakdown of Value Sales for Contrast Media and Radiopharmaceuticals for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings